Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abvc Biopharma (ABVC) Return on Assets (2016 - 2025)

Historic Return on Assets for Abvc Biopharma (ABVC) over the last 13 years, with Q3 2025 value amounting to 0.29%.

  • Abvc Biopharma's Return on Assets rose 3700.0% to 0.29% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.29%, marking a year-over-year increase of 3700.0%. This contributed to the annual value of 0.74% for FY2024, which is 2800.0% up from last year.
  • Latest data reveals that Abvc Biopharma reported Return on Assets of 0.29% as of Q3 2025, which was up 3700.0% from 0.29% recorded in Q2 2025.
  • In the past 5 years, Abvc Biopharma's Return on Assets ranged from a high of 0.29% in Q3 2025 and a low of 1.63% during Q4 2022
  • Over the past 5 years, Abvc Biopharma's median Return on Assets value was 0.95% (recorded in 2021), while the average stood at 0.96%.
  • Its Return on Assets has fluctuated over the past 5 years, first crashed by -7000bps in 2022, then surged by 9800bps in 2025.
  • Abvc Biopharma's Return on Assets (Quarter) stood at 0.92% in 2021, then tumbled by -76bps to 1.63% in 2022, then surged by 56bps to 0.71% in 2023, then increased by 3bps to 0.69% in 2024, then skyrocketed by 58bps to 0.29% in 2025.
  • Its Return on Assets was 0.29% in Q3 2025, compared to 0.29% in Q2 2025 and 0.29% in Q1 2025.